Ose Immunotherapeutics SA (OSE) Stock Price & News

OSE:EPA

Ose Immunotherapeutics SA

1,74 €

-1,19%

(-0,021) 1D

5-ноя., 17:35:05 GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for OSE...

Open

1,74 €

High

1,82 €

Low

1,74 €

Mkt. cap

40,38 млн

Avg. vol.

176,23 миң

Volume

151,05 миң

52-wk high

5,92 €

52-wk low

1,74 €

EPS

-1,69 €

Shares outstanding

23,56 млн

No. of employees

Open

1,74 €

High

1,82 €

Low

1,74 €

Mkt. cap

40,38 млн

Avg. vol.

176,23 миң

Volume

151,05 миң

52-wk high

5,92 €

52-wk low

1,74 €

EPS

-1,69 €

Shares outstanding

23,56 млн

No. of employees

Related stocks

News stories

From web sources and news partners

FOREX.com

7 мүнөт мурун

Nasdaq volatility shock warns against buying too early

seMissourian

57 мүнөт мурун

Brutal sell-off for AI stocks sends Wall Street reeling, S&P 500 tumbles 4.4%

Open Magazine

25 мүнөт мурун

EXPLAINED | $2.5 Trillion Wiped Off the Nasdaq 100. Why Did the Democrats’ ‘Blue Tsunami’ Spook AI Investors?

Yahoo Finance

1 саат мурун

S&P 500, Nasdaq, Dow Futures Dip As Investors Step Back From AI And Tech With Nasdaq In Correction Territory — NVDA, AAPL, UBER, SOXX In Focus

About Ose Immunotherapeutics SA

CEO-

Employees64

Founded2004-ж., 17-ноя.

Headquarters-

SectorHealth Care

Industry-

Websiteose-immuno.com

All values in EUR	2024-ж. сен.	2024-ж. дек.
Revenue	431,00 миң	431,00 миң
Cost of goods sold	-	-
Cost of revenue	-	-
Research and development expenses	8,28 млн	8,28 млн
Total research and development expenses	-	-
Selling, general, and admin expenses	1,08 млн	1,08 млн
Operating expense	10,22 млн	10,22 млн
Total operating expenses	10,22 млн	10,22 млн
Operating income	-9,79 млн	-9,79 млн
Other non operating income	-611,00 миң	-611,00 миң
EBT including unusual items	-10,44 млн	-10,44 млн
EBT excluding unusual items	-10,53 млн	-10,53 млн
Income tax expense	-576,50 миң	-576,50 миң
Effective tax rate	5,52%	5,52%
Other operating expenses	41,00 миң	41,00 миң
Net income	-9,86 млн	-9,86 млн
Net profit margin	-2 288,86%	-2 288,86%
Earnings per share	-	-
Interest and investment income	571,00 миң	571,00 миң
Interest expense	-707,50 миң	-707,50 миң
Net interest expenses	-136,50 миң	-136,50 миң
Depreciation and amortization charges	-	-
EBITDA	-9,74 млн	-9,74 млн
Gain or loss from assets sale	-	-

Ask anything